Expertise in
8
conditions

Bernhard Ludvik

Krankenanstalt Rudolfstiftung
Vienna, AT 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
8
conditions
Krankenanstalt Rudolfstiftung
Vienna, AT 

Overview

Bernhard Ludvik practices practicing medicine in Vienna, Austria.

Mr. Ludvik is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Obesity, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Peripheral Artery Disease, and Gastric Bypass.

He is actively involved in clinical research, co-authoring 103 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Krankenanstalt Rudolfstiftung
Vienna, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

NT-proBNP Selected PreventiOn of Cardiac eveNts in a populaTion of dIabetic Patients Without A History of Cardiac Disease: a Prospective Randomized Trial
NT-proBNP Selected PreventiOn of Cardiac eveNts in a populaTion of dIabetic Patients Without A History of Cardiac Disease: a Prospective Randomized Trial
Enrollment Status: Recruiting
Publish Date: March 14, 2023
Intervention Type: Drug, Other
Study Drug: RAS-antagonist and beta-blocker up-to maximal dosages
Study Phase: Phase 4
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
Enrollment Status: Completed
Publish Date: October 27, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: January 19, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Enrollment Status: Completed
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

103 Total Publications

Semaglutide in peripheral artery disease and diabetes by baseline disease severity and age: the STRIDE trial.
Semaglutide in peripheral artery disease and diabetes by baseline disease severity and age: the STRIDE trial.
Journal: European heart journal
Published: March 04, 2026

Frequently Asked Questions about Bernhard Ludvik

Is Bernhard Ludvik a top-rated expert for Obesity?

MediFind is an objective health platform that identifies experts based on real-world data. Bernhard Ludvik is classified as an Elite expert for Obesity, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Bernhard Ludvik participate in research or clinical trials?

Yes. Bernhard Ludvik has published 103 articles and abstracts on conditions like Obesity. You can view a list of Bernhard Ludvik's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ludvik's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile